We have previously shown that when CML CD34+ cells are exposed to TKIs in vitro this leads to increased numbers of quiescent CD34+ CML cells compared to untreated cells 11,12,34. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.